Frederick Health expands outpatient facilities, launches precision medicine program | Hospitals And Doctors

Frederick Health will take new patients to its North Frederick campus this month after expanding outpatient…

Hematology Workforce Shortage Poses Challenges for Cancer Care

Demand for hematology professionals – including both physicians and nurse practitioners (NPs) and physician associates (PAs),…

Editas Rumored to be in “Advanced Discussions” around Potential Sale of Oncology Assets

From left: Editas CMO Baisong Mei and CEO Gilmore O’Neill/Courtesy of Editas Medicine Editas Medicine, a…

Oncology Nutrition Market With Top 20 Countries data Analysis, Growth by Top Companies, Trends by Types and Application, Forecast Analysis to 2028 | Danone, Nestle S.A., B. Braun Melsungen AG, Abbott Laboratories,

Oncology Nutrition Market research report contains all industry related information. It offers market insights by providing…

Annual Pink Event slated for Saturday; raises awareness of cancer and funds for patients

A Pink Event – MLC Cancer Foundation’s Breast Cancer Wellness Symposium & Fundraiser will be held…

Radiation oncology research and clinical trial results to be featured at ASTRO’s Annual Meeting in San Antonio

Newswise – ARLINGTON, Va., October 4, 2022 – The American Society for Radiation Oncology (ASTRO) today…

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cullinan Oncology, Inc. CAMBRIDGE, Mass., Oct. 3, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM)…

Cullinan Oncology Reports Inducement Grants Under Nasdaq

CAMBRIDGE, Mass., Oct. 3, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) announced today…

Synthetic Biologics Announces Presentation at SIOP International Society of Pediatric Oncology on New Preclinical Data Supporting Evaluation of VCN-01 and Topotecan for the Treatment of Refractory Retinoblastoma

Synthetic Biologics, Inc. Preclinical results showed that treatment with topotecan enhanced the oncolytic activity of VCN-01…

Mersana Therapeutics Announces Launch of Oncology FACETS, a Resource for Healthcare Providers to Advance Knowledge in Gynecologic Malignancies

Get instant notifications when there’s news about your stocks. Claim your 1 week free trial StreetInsider…